Register
Login:
Share:
Email Facebook Twitter


London South East - Oil & Gas Investor Evening: Malcy, Echo, Savannah, SDX
Andrew Knott, #SAVP speaks at London South East's Oil & Gas event


RBS Regulatory News (RBS)



Regulatory News for RBS (RBS)


Share Price: 231.20Bid: 231.20Ask: 231.30Change: -3.80 (-1.62%)Faller - Royal Bank Scot
Spread: 0.10Spread as %: 0.04%Open: 233.00High: 233.50Low: 231.10Yesterday’s Close: 235.00





EC formally approves Alternative Remedies Package

Mon, 18th Sep 2017 17:15

RNS Number : 0849R
Royal Bank of Scotland Group PLC
18 September 2017
 

 

European Commission formally approves Alternative Remedies Package in relation to RBS's remaining State Aid commitments

18 September 2017

           

RBS has received confirmation that an alternative remedies package announced on 26 July 2017 (the "Alternative Remedies Package"), regarding the business previously described as Williams & Glyn, has now been formally approved by the European Commission ("EC") in the form proposed. 

                  

The Alternative Remedies Package forms the basis of a new agreement in relation to RBS's remaining State Aid commitments and replaces the existing requirement to divest the business previously described as Williams & Glyn by 31 December 2017. 

 

The Alternative Remedies Package is focused on the following two remedies to promote competition in the market for banking services to small and medium-sized enterprises ("SMEs") in the UK:

 

·      A £425m Capability and Innovation Fund that will grant funding to a range of competitors in the UK banking and financial technology sectors; and

·      A £350m Incentivised Switching Scheme which will provide funding for eligible challenger bodies to help them incentivise SME customers of the business previously described as Williams & Glyn to switch their accounts and loans from RBS paid in the form of "dowries" to the receiving bank. In addition, under the terms of the Alternative Remedies Package, should the uptake within the Incentivised Switching Scheme not be sufficient, RBS may be required to make a further contribution, capped at £50m.

An Independent Body (the "IB") will be established to administer the Alternative Remedies Package. RBS will make an upfront contribution of £20m to cover certain operational expenses of the IB relating to the Alternative Remedies Package. 

RBS has agreed to provide separate indemnities to each of the IB and Her Majesty's Treasury (HMT) to cover liabilities that may be incurred in implementing the Alternative Remedies Package. Whilst no such liabilities may ever arise, these indemnities collectively are capped at a maximum amount of £320m. Accordingly, the Alternative Remedies Package remains consistent with the £800m provision that RBS took in relation to the expected costs of the package in H2 2016 and H1 2017.

Ross McEwan, RBS CEO, said "We are pleased that we now have final approval from the European Commission for the Alternative Remedies Package. This allows us to resolve our final State Aid divestment obligation and brings welcome clarity for our customers and staff.

It also builds on the progress we have made already this year in resolving our major legacy issues through reaching a settlement with the Federal Housing Finance Agency, and resolving the 2008 Rights Issue litigation. We remain committed to resolving our last remaining major legacy issue, the investigation into our historic US RMBS activities."   

This transaction is a smaller related party transaction, with HMT, under LR 11.1.10R.

Investor Relations

+44 (0)20 7672 1758

                      

Media relations

+44 (0)131 523 4205

 

 

Forward Looking Statements

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

MAR

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR).  For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMLVRGGNZM






DateSourceHeadlineCategory
01-Oct-18 15:00RNSDirector/PDMR ShareholdingDirectors' Dealings
28-Sep-18 12:32RNSTotal Voting RightsHolding(s) in Company
25-Sep-18 11:23RNSPricing of USD Fixed Rate to Floating Rate NotesCompany Announcement - General
25-Sep-18 07:00RNSBofAML Annual Financial CEO ConferenceCompany Announcement - General
24-Sep-18 09:00RNSRBS Investor SeminarUK Personal & Business BankingCompany Announcement - General
17-Sep-18 12:05RNSPublication of Final TermsCompany Announcement - General
13-Sep-18 08:00RNSBarclays Global Financial Services ConferenceCompany Announcement - General
03-Sep-18 18:00RNSPublication of Final TermsCompany Announcement - General
31-Aug-18 16:42RNSTotal Voting RightsHolding(s) in Company
31-Aug-18 16:15RNSNatWest Markets N.V. Interim Results 2018Results and Trading Reports
22-Aug-18 17:01RNSDividend DeclarationDividends
21-Aug-18 15:32RNSPublication of Suppl.ProspctsCompany Announcement - General
17-Aug-18 07:00RNSDirectorate ChangeExecutive Changes
15-Aug-18 07:00RNSDeclaration of Interim DividendDividends
13-Aug-18 09:00RNSUpdate on ring-fencing plansCompany Announcement - General
06-Aug-18 11:20RNSPublication of Suppl.ProspctsCompany Announcement - General
03-Aug-18 07:00RNSHalf-year ReportResults and Trading Reports
31-Jul-18 14:44RNSUpdate on ring-fencing plansCompany Announcement - General
31-Jul-18 12:04RNSTotal Voting RightsHolding(s) in Company
17-Jul-18 11:46RNSRBS welcomes credit ratings action by Moody'sCompany Announcement - General
16-Jul-18 18:18RNSAllotment and Issue of New Ordinary SharesCompany Announcement - General
02-Jul-18 14:47RNSCapital reduction - notice of completionCompany Announcement - General
29-Jun-18 12:51RNSTotal Voting RightsHolding(s) in Company
25-Jun-18 11:52RNSPublication of Final TermsCompany Announcement - General
22-Jun-18 17:28RNSPublication of Final TermsCompany Announcement - General
21-Jun-18 11:52RNSPricing of USD Dual-Tranche NotesCompany Announcement - General
08-Jun-18 09:23RNSTR-1 Notification of major shareholdingsHolding(s) in Company
07-Jun-18 09:00RNSGoldman Sachs European Financials ConferenceCompany Announcement - General
05-Jun-18 07:00RNSDisposal of approximately 7.7% of RBS Group plc.Mergers, Acquisitions and Disposals
04-Jun-18 16:36RNSIntention to dispose of c7.7% of RBS Group plc.Company Announcement - General


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.